tiprankstipranks
Advertisement
Advertisement

TARS Stock Latest News

Tarsus Pharmaceuticals price target raised to $101 from $100 at Mizuho
The FlyTarsus Pharmaceuticals price target raised to $101 from $100 at Mizuho
1d ago
TARS
Tarsus Pharmaceuticals to receive $15M milestone on China TP-03 approval
PremiumThe Fly
Tarsus Pharmaceuticals to receive $15M milestone on China TP-03 approval
4d ago
TARS
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth
PremiumCompany Announcements
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth
17d ago
TARS
Tarsus Pharmaceuticals price target raised to $105 from $95 at Oppenheimer
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $105 from $95 at Oppenheimer
30d ago
TARS
Tarsus Pharmaceuticals price target raised to $90 from $87 at Guggenheim
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $90 from $87 at Guggenheim
30d ago
TARS
Tarsus Pharmaceuticals rises 11.6%
PremiumThe FlyTarsus Pharmaceuticals rises 11.6%
1M ago
TARS
Tarsus Pharmaceuticals price target raised to $90 from $88 at BofA
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $90 from $88 at BofA
1M ago
TARS
Sustained Growth Outlook for Tarsus Driven by XDEMVY’s Rapid Ramp and Expanding Lotilaner Pipeline
Premium
Ratings
Sustained Growth Outlook for Tarsus Driven by XDEMVY’s Rapid Ramp and Expanding Lotilaner Pipeline
1M ago
TARS
Tarsus: Strong Xdemvy Launch, Upgraded Long‑Term Outlook, and Underappreciated Earnings Power Support Buy Rating
PremiumRatings
Tarsus: Strong Xdemvy Launch, Upgraded Long‑Term Outlook, and Underappreciated Earnings Power Support Buy Rating
1M ago
TARS
Tarsus: Raising Peak Xdemvy Outlook to $2B+ on Strong Q4 Momentum and Pipeline Upside
PremiumRatings
Tarsus: Raising Peak Xdemvy Outlook to $2B+ on Strong Q4 Momentum and Pipeline Upside
1M ago
TARS
Tarsus Pharmaceuticals reports Q4 EPS (20c), consensus (13c)
PremiumThe Fly
Tarsus Pharmaceuticals reports Q4 EPS (20c), consensus (13c)
1M ago
TARS
TARS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TARS Upcoming Earnings Report: What to Expect?
1M ago
TARS
Tarsus Pharmaceuticals Adds Industry Veteran to Board
PremiumCompany AnnouncementsTarsus Pharmaceuticals Adds Industry Veteran to Board
1M ago
8K
TARS
Tarsus Pharmaceuticals appoints Pyott to Board of Directors
Premium
The Fly
Tarsus Pharmaceuticals appoints Pyott to Board of Directors
1M ago
TARS
Tarsus Pharmaceuticals price target raised to $68 from $51 at Goldman Sachs
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $68 from $51 at Goldman Sachs
2M ago
TARS
Top 5 Trending Stocks by Unusual Trading Volume, 12/31/25
PremiumMarket News
Top 5 Trending Stocks by Unusual Trading Volume, 12/31/25
3M ago
FG
NEU
Tarsus Pharmaceuticals initiated with an Overweight at Barclays
PremiumThe Fly
Tarsus Pharmaceuticals initiated with an Overweight at Barclays
4M ago
TARS
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
PremiumThe Fly
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
4M ago
TARS
Tarsus Pharmaceuticals price target raised to $51 from $45 at Goldman Sachs
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $51 from $45 at Goldman Sachs
5M ago
TARS
Tarsus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsTarsus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
5M ago
TARS
Tarsus Pharmaceuticals: Strong Market Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Tarsus Pharmaceuticals: Strong Market Performance and Growth Potential Justify Buy Rating
5M ago
TARS
Strong Market Position and Growth Potential Drive Buy Rating for Tarsus Pharmaceuticals
Premium
Ratings
Strong Market Position and Growth Potential Drive Buy Rating for Tarsus Pharmaceuticals
5M ago
TARS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >